A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...
A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.
According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...
Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.
An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.
Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...
A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...
Avelox (moxifloxacin), Levaquin (levoflaxoacin), and Cipro (ciprofloxacin) are antibiotics in the class known as fluoroquinolones and are used to treat serious bacterial infections, including urinary tract, sinus, and ear infections. The drugs have also been tied to serious side effects … Continue reading →
Ciprofloxacin is a fluoroquinolone antibiotic that fights different types of bacterial infections, such as urinary tract or gastrointestinal infections. It is also used to treat people who have been exposed to anthrax. Ciprofloxacin should only be used for infections that … Continue reading →
The fluoroquinolone antibiotic Cipro (ciprofloxacin) is one the medications linked to the extreme allergic reaction Stevens-Johnson syndrome (SJS). Though Stevens-Johnson is not common, it can be fatal if not treated quickly, according to Top Class Actions.
Johnson & Johnson faces a new wave of lawsuits in federal court in New Jersey alleging its antibiotic Levaquin caused nerve damage. From August 1 to 11, 13 Levaquin suits with 18 plaintiffs were filed against Johnson & Johnson and … Continue reading →
According to a new report, antibiotics in the same class as Avelox (moxifloxacin) were the drugs most frequently associated with reports of persistent adverse effects in 2015. The report appeared in QuarterWatch, a publication of the Institute for Safe Medication … Continue reading →
Fluoroquinolones are a class of antibiotics that include ciprofloxacin (brand names: Cipro, Cetraxal and Proquin), levofloxacin (Levaquin, Quixin and Iquix), moxifloxacin (brand name: Avelox), gemifloxacin (brand name: Factive) and ofloxacin (brand name: Ofloxacin). One potential side effect that may occur … Continue reading →
In May 2016, the U.S. Food and Drug Administration (FDA) warned about the risks of fluoroquinolone antibiotics, which include Levaquin, Avelox and Cipro. The agency said that, given the risk of potentially permanent side effects, these medications should only be … Continue reading →
The U.S. Food and Drug Administration (FDA) has approved labeling changes on fluoroquinolone antibiotics, which include levofloxacin (Levaquin), ciprofloxacin (Cipro), ciprofloxacin extended-release tablets, moxifloxacin (Avelox), ofloxacin and gemifloxacin (Factive). In a news release issued Tuesday, the agency said the Boxed … Continue reading →
Hundreds of product liability lawsuits involving the fluoroquinolone antibiotics Levaquin, Cipro and Avelox are moving toward trial in a multidistrict litigation (MDL) in the U.S. District Court, District of Minnesota. In June 2016, the court granted a motion from the … Continue reading →
New studies have found that people taking fluoroquinolone antibiotics such as Cipro, Levaquin and Avelox are 2 to 3 times more susceptible to life-threatening damage to their aorta. The aorta is the body’s main artery that carries oxygenated blood from … Continue reading →